Patent assignee · US · COMPANY

CELLSCRIPT, LLC

14Patents

13Active

14Granted

55Portfolio score

Filing activity: Nov 21, 2003 → Aug 31, 2021 · 3 expiring within 5 years

Most-cited patents

Patent	Title	Area	Cited by	Status
US8846348B2	Kits and methods for generating 5′ capped RNA	Chemistry; Metallurgy	101	Active
US8808982B2	Compositions and methods for reprogramming eukaryotic cells	Chemistry; Metallurgy	96	Active
US8039214B2	Synthesis of tagged nucleic acids	Chemistry; Metallurgy	70	Active
US8329887B2	Synthesis of tagged nucleic acids	Chemistry; Metallurgy	67	Active
US8304183B2	Selective terminal tagging of nucleic acids	Chemistry; Metallurgy	56	Active
US8137911B2	Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences	Chemistry; Metallurgy	48	Expired
US9005930B2	Kits and methods for generating 5′ capped RNA	Chemistry; Metallurgy	45	Active
US9115380B2	Kits and methods for generating 5′ capped RNA	Chemistry; Metallurgy	15	Active
US10201620B2	Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect	Emerging Cross-Sectional Technologies	8	Active
US9862926B2	Inhibition of innate immune response	Chemistry; Metallurgy	6	Active
US9017970B2	RNA polyphosphatase compositions, kits, and uses thereof	Emerging Cross-Sectional Technologies	1	Active
US10793831B2	Inhibition of innate immune response	Chemistry; Metallurgy	0	Active
US12059479B2	Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect	Emerging Cross-Sectional Technologies	0	Active
US11135314B2	Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect	Emerging Cross-Sectional Technologies	0	Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.